Selective STING Activation in Intratumoral Myeloid Cells via CCR2-Directed Antibody-Drug Conjugate TAK-500.
Appleman VA, Matsuda A, Ganno ML, Zhang DM, Rosentrater E, Maldonado Lopez AE, Porciuncula A, Hatten T, Christensen CL, Merrigan SA, Lee HM, Lee MY, Wang CI, Dong L, Huang J, Iartchouk N, Wang J, Xu H, Yoneyama T, Piatkov KI, Haridas S, Harbison CE, Gregory RC, Parent A, Lineberry N, Arendt C, Schalper KA, Abu-Yousif AO.
Appleman VA, et al. Among authors: christensen cl.
Cancer Immunol Res. 2025 May 2;13(5):661-679. doi: 10.1158/2326-6066.CIR-24-0103.
Cancer Immunol Res. 2025.
PMID: 39918395
Free PMC article.